Lung Cancer Screening Promotion for Lung Cancer

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Abramson Cancer Center at Penn Medicine

Disqualifiers: Not eligible for screening, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

34 Participants Needed

Trial Summary

What is the purpose of this trial?

Project PLUS is a pilot study that aims to develop and obtain preliminary feasibility and efficacy data on an enhanced risk communication approach to promote lung cancer screening (LCS) intentions among screening-eligible individuals from environmentally burdened communities. Project PLUS will combine qualitative interviews to explore subject awareness regarding lung cancer risk and air pollution, barriers to LCS, and perceptions regarding risk communication messaging, develop a health education video, and a between-subjects experiment to compare Data from this pilot will form the basis for enhanced community engagement efforts and subsequent communication research to examine the effectiveness of incorporating the involuntary air pollution risk information in risk communication interventions. The long term goal is to reduce lung cancer burden and disparities among environmentally burdened communities within and outside of Philadelphia.

Research Team

Katharine Rendle, PhD,MSW,MPH

Principal Investigator

University of Pennsylvania

Andy Tan, PhD,MPH,MBA

Principal Investigator

University of Pennsylvania

Eligibility Criteria

This trial is for individuals aged 50-80 who have a significant history of smoking and have visited Penn Medicine in the last two years. They must live in specific zip codes, speak English, and be able to view videos and take surveys online. Those with previous lung cancer screenings or diagnoses are excluded.

Inclusion Criteria

Patient interview participants: Ages 50 - 80 years

Participants must be between 50 and 80 years old.

Patient interview participants: Able to participate in a video-conference interview using a HIPAA-compliant platform or able to participate in an interview over the phone

Exclusion Criteria

Pilot trial participants: Do not meet inclusion criteria

You have already taken part in interviews with patients as part of a trial.

Patient interview participants: Not eligible for lung cancer screening

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants view a health education video about smoking and environmental risks

1 day

1 visit (in-person or virtual)

Follow-up

Participants are monitored for lung cancer screening completion and intentions

6 months

Treatment Details

Interventions

• Control video
• Intervention video

Trial Overview Project PLUS tests an enhanced risk communication approach to encourage lung cancer screening intentions among people from areas with high environmental pollution. It involves comparing reactions to an intervention video versus a control video after conducting qualitative interviews.

Participant Groups

Group I: Intervention Arm Experimental Treatment 1 Intervention

This arm includes patients who view the integrated health video that provides information about both smoking and environmental risk.

Group II: Control Video Arm Experimental Treatment 1 Intervention

This arm includes patients who view the integrated health video that provides information ONLY about smoking risk.

Who Is Running the Clinical Trial?

Abramson Cancer Center at Penn Medicine

Lead Sponsor

Trials

425

Recruited

464,000+